拱东医疗 (605369.SH) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	1.2B	1.1B	1.1B	975.1M	1.5B
Cost of Revenue	835.3M	819.2M	749.5M	656.7M	888.6M
Gross Profit	324.5M	316.5M	365.7M	318.4M	580.1M
Operating Expenses
R&D Expense	46.6M	45.6M	53.0M	47.8M	72.3M
SG&A Expense	—	—	—	—	—
General & Admin Expense	91.6M	92.9M	89.2M	83.1M	99.1M
Selling & Marketing Expense	55.9M	56.0M	52.0M	65.1M	63.4M
Other Expenses	—	—	—	—	—
Total Operating Expenses	209.9M	204.1M	180.8M	202.9M	203.3M
Cost and Expenses	1.0B	1.0B	930.2M	859.6M	1.1B
Operating Income (EBIT)	74.8M	65.2M	191.6M	119.7M	371.8M
Non-Operating
Interest Income	—	—	—	—	—
Interest Expense	—	—	—	—	—
Net Interest Income	—	—	—	—	—
Other Non-Op Income/Expense	—	—	—	—	—
Non-Operating Income (excl Interest)	—	—	—	—	—
EBT (Pre-Tax Income)	72.9M	62.8M	188.7M	119.2M	370.7M
Income Tax Expense	16.8M	11.5M	17.2M	10.1M	44.6M
Bottom Line
Net Income	56.1M	51.5M	171.6M	109.1M	326.0M
Earnings from Cont. Ops	56.1M	51.4M	171.5M	109.1M	326.0M
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	56.1M	51.5M	171.6M	109.1M	326.0M
Per Share
Basic EPS	CN¥0.26	CN¥0.23	CN¥0.78	CN¥0.69	CN¥2.91
Diluted EPS	CN¥0.26	CN¥0.23	CN¥0.78	CN¥0.69	CN¥2.91
Revenue Per Share	CN¥5.44	CN¥5.07	CN¥5.07	CN¥6.17	CN¥13.11
Shares
Basic Shares Outstanding	213.3M	223.9M	220.0M	158.2M	112.0M
Diluted Shares Outstanding	213.3M	223.9M	220.0M	158.2M	112.0M
Profitability Metrics
EBITDA	—	168.2M	287.1M	205.4M	412.5M
D&A	—	103.0M	95.5M	85.7M	40.7M
EBIT	—	—	—	—	—

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026